MedTrace Logo

A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

NCT01271959 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2012-10-05

No results posted yet for this study

Summary

The purpose of this research study is to collect information from patient's medical records that had a test called ChemoFx® ordered and to understand how doctors may have used the results of the ChemoFx® to treat patients with cancer.

Conditions

  • Solid Organ Tumors

Sponsors & Collaborators

  • Precision Therapeutics

    lead INDUSTRY

Principal Investigators

  • Karl Williams, M.D. · Precision Therapeutics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271959 on ClinicalTrials.gov